WO2014018847A1 - Dual cap system for container-closures to maintain tip sterility during shelf storage - Google Patents
Dual cap system for container-closures to maintain tip sterility during shelf storage Download PDFInfo
- Publication number
- WO2014018847A1 WO2014018847A1 PCT/US2013/052237 US2013052237W WO2014018847A1 WO 2014018847 A1 WO2014018847 A1 WO 2014018847A1 US 2013052237 W US2013052237 W US 2013052237W WO 2014018847 A1 WO2014018847 A1 WO 2014018847A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cap
- container
- vented
- dispensing tip
- vented cap
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/065—Rigid ampoules, e.g. glass ampoules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1425—Snap-fit type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/18—Arrangements for indicating condition of container contents, e.g. sterile condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2037—Separating means having valve means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2068—Venting means
- A61J1/2072—Venting means for internal venting
Definitions
- a container-closure system includes a container configured to hold a therapeutic liquid and having a dispensing tip configured to dispense a dose of the therapeutic liquid.
- a vented cap is configured to fit over at least a portion of the container including the dispensing tip and having one or more vents that allow air to pass into and out of a cavity defined between the vented cap and the dispensing tip.
- a second cap is configured to fit over at least a portion of the vented cap.
- a tamper evident seal is coupled to the second cap and one or both of the container and the vented cap.
- the container is configured to dispense a plurality of single doses of the therapeutic liquid in the form of an ophthalmic solution, emulsion or suspension.
- the therapeutic agent is selected from the group consisting of bimatoprost, brimonidine, timolol, cyclosporine, gatifloxacin,
- one or more vents in the vented cap are configured to allow passage of air into and out of the cavity sufficient to accelerate drying of residual therapeutic liquid at the dispensing tip of the container after dispensing the therapeutic liquid dose.
- the second cap is configured to be twisted and removed from the apparatus, and the tamper evident seal is configured to break in response to the twisting of the second cap.
- the vented cap and the second cap define an integral structure, and the tamper evident seal is configured to break away from the second cap.
- the vented cap, the second cap, and the tamper evident seal define an integral structure, and the tamper evident seal is configured to break away from the vented cap and the second cap.
- the second cap defines a second vented cap, and twisting the second vented cap relative to the container causes vents of the vented cap and the second vented cap to overlap.
- the vented cap comprises a protrusion arranged on the vented cap to establish contact with the dispensing tip of the container when the vented cap is fitted on the container.
- the protrusion is configured to seal the dispensing tip of the container when the vented cap is fitted on the container.
- the second cap comprises a desiccant system.
- one or both of the dispensing tip of the container and the vented cap comprise an antimicrobial.
- the therapeutic liquid is a preservative- free therapeutic liquid.
- the container comprises a uni-directional valve situated at the dispensing tip and configured to prevent fluid return into the container.
- the unidirectional valve is configured to prevent contamination of the therapeutic liquid from a source external to the container.
- the container and the dispensing tip are formed of one or more polymers selected from the group consisting of low-density polyethylene, high-density polyethylene, and high-impact polystyrene.
- a method involves storing a therapeutic liquid in a reservoir of a container configured to hold the therapeutic liquid.
- the container comprises a dispensing tip configured to dispense a dose of the therapeutic liquid.
- a vented cap is configured to fit over at least a portion of the container including the dispensing tip and having one or more vents that allow air to pass into and out of a cavity defined between the vented cap and the dispensing tip.
- a second cap is configured to fit over at least a portion of the vented cap.
- a tamper evident seal is coupled to the second cap and one or both of the container and the vented cap.
- the container is configured to dispense a plurality of single doses of the therapeutic liquid in the form of an ophthalmic solution, emulsion or suspension.
- a method involves removing a cap from a container configured a hold the therapeutic liquid, the container comprising a dispensing tip configured to dispense a dose of the therapeutic liquid.
- the cap comprises a vented cap configured to fit over at least a portion of the container including the dispensing tip and having one or more vents that allow air to pass into and out of a cavity defined between the vented cap and the dispensing tip.
- a second cap is configured to fit over at least a portion of the vented cap.
- the method further includes dispensing the therapeutic liquid from the container.
- Figures 1 and 2 show a container-closure system that includes a vented cap, an over cap, and a tamper evident configured to be broken causing the tamper-evident seal and the over cap to be removed from the container;
- Figures 3 and 4 illustrate a container-closure system that includes a vented cap, an over cap, and a tamper evident seal configured to be broken causing the tamper- evident seal to be removed from the container without removing the over cap;
- Figures 5-7 show container-closure systems in which the over cap includes one or more vents and is configured to be rotated with respect to the vented cap and the container, such that at least one vent disposed on the over cap and at least one vent disposed on the vented cap can overlap.
- Embodiments of the disclosure are generally directed to container-closure and drug delivery systems.
- the container-closure or drug delivery systems are configured for dispensing multiple single doses of a therapeutic agent in the form of a solution, emulsion or suspension through a dispensing tip. After administering a dose of the therapeutic agent, residual amounts of the agent and/or other contaminants, such as bodily fluids, may remain on the outside surface of the dispensing tip. The residual material that is left on the dispensing tip has the potential to promote microbial growth. Vents may be added to a cap of the container to accelerate drying time of the residual agent and thus reducing the potential for microbial growth.
- the vents in the cap may decrease the sterility of the container by allowing ambient air to come into contact with the dispensing tip.
- An over cap is arranged over at least a portion of the vented cap, covering the vents on the vented cap and reducing the potential for the sterility of the dispensing tip being compromised.
- FIG. 1 and 2 there is illustrated a container-closure system that includes a vented cap and a non- vented cap.
- the container-closure 100, 200 shown in Figures 1 and 2 and other figures may be configured to dispense a preservative-free therapeutic agent.
- the container-closure system 100, 200 includes a container 110, 210 having an enclosure 120, 220 configured to store a therapeutic liquid therein.
- the enclosure 120, 220 is sterile in various embodiments where the enclosure 120, 220 is implemented to store a therapeutic liquid.
- the container-closure embodiment depicted in Figures 1 and 2 and other figures can also be configured for dispensing therapeutic agents that include a preservative.
- the container 1 10, 210 has a dispensing tip 130, 230 through which the therapeutic liquid is dispensed.
- the dispensing tip 130, 230 has a generally tapered, conical shape that is appropriately dimensioned for dispensing the therapeutic agent to a localized portion of a user's body, such as the eyes, nostrils, and/or ears.
- the enclosure 1 10, 210 can be implemented to contain a preservative-free ophthalmic therapeutic agent and the dispensing tip 130, 230 may be configured to enable a user to dispense the ophthalmic therapeutic agent multiple times to the eyes over an extended period of time, such as one month.
- the container and the dispensing tip may be formed of low-density polyethylene, high-density polyethylene, and/or high- impact polystyrene.
- a variety of therapeutic agents can be dispensed using container-closure systems implemented in accordance with embodiments of the disclosure.
- a non- limiting, non-exhaustive list of such therapeutic agents includes bimatoprost, brimonidine, timolol, cyclosporine, gatifloxacin, ocufloxacin, prednisolone, carnitine and ketorolac.
- the systems implemented in accordance with embodiments of the disclosure are not limited to delivery of preservative-free therapeutic agents, but can also be applied to delivery of preserved therapeutic agents.
- the container 110, 210 includes a
- the unidirectional valve which may optionally include a filter.
- the unidirectional valve is configured to allow the therapeutic agent contained within the container to pass through to the dispensing tip 130, 230, but prevents re-entry of the therapeutic agent and/or other fluids or contaminants into the container.
- Various types of valves can be implemented to provide unidirectional flow of fluid from the container to the dispensing tip 130, 230, including the Novelia valve available from Rexam and the valve system of the Ophthalmic Squeeze Dispenser available from Aptar Pharma, for example.
- the container 110, 210 is configured to dispense a single dose of the therapeutic agent on a repeated basis over a predetermined duration of time.
- the container 1 10, 210 can be configured to dispense single doses of the therapeutic agent each day for a month.
- the container 1 10, 210 is configured to dispense a predetermined volume of the therapeutic agent as a single dose.
- the unidirectional valve can be configured to regulate the volume of the therapeutic agent so that a metered dose of the therapeutic agent is dispensed during each application. Suitable precision metering valves are available from Rexam, for example. Also, various available spring-loaded unidirectional valves can be used that open during actuation to deliver a single dose of drug product.
- the valve After actuation, the valve returns to its original position and seals the opening.
- the container-closure system described herein can be implemented with a squeezable vessel.
- a pump mechanism can be implemented to facilitate metered or unmetered dispensing of a therapeutic agent contained within the container 110, 210.
- a vented cap 140, 240 that includes one or more vents 145 is fitted over at least a portion of the container 110, 210 allowing passage of ambient air between the vented cap 140, 240 and the dispensing tip 130, 230.
- the one or more vents 145 may be configured to allow passage of air into and out of a cavity between the dispensing tip 130, 230 and the vented cap 140, 240 sufficient to accelerate drying of residual therapeutic liquid and/or other contaminants at the dispensing tip 130, 230 of the container 1 10, 210 after dispensing the therapeutic liquid dose.
- the container-closure system 100, 200 shown in Figures 1 and 2 and other figures includes a protrusion 140, 240 which is configured to releasably engage a distal portion of the dispensing tip 130, 230.
- a seal is formed between the vented cap 140, 240 and the dispensing tip 130, 230.
- the seal can be implemented to provide a desired degree of sealing (e.g., fluid-tight, air-tight, or mechanically tight).
- An over cap 160 is fitted over at least a portion of the vented cap 140.
- the over cap 160 covers the one or more vents 145 to help maintain sterility during storage of the container 1 10.
- the over cap 160 and the vented cap 140 define an integral structure. According to various implementations described herein, the over cap 160 is configured to be removed from the vented cap 140.
- antimicrobial additives are provided at selected surfaces of the container-closure system, such as on surfaces of a dispensing tip, the vented cap, and/or the over cap which are susceptible to microbial
- a variety of ophthalmic multi-dose container-closure systems and drug delivery systems can benefit from inclusion of antimicrobial surface protection according to embodiments of the disclosure, including those that contain unpreserved, partially preserved, and preserved ophthalmic products.
- antimicrobial additives can be incorporated in a coating that can be applied to polymeric material suitable for fabricating container- closure systems according to other embodiments of the disclosure: silver nanoparticles, biosafe, IRGAGUARD® F3000, Triclosan, zinc omadine, zinc ion, cupper ion, cerium ion, GOLDSHIELD®, AEGISTM antimicrobial, PEI-TCS polymers, protamine sulfate and chlorhexidine, alone or in any combination thereof.
- One or more of the vented cap, the over cap, and the dispensing tip may include a desiccant system to promote accelerated drying of residual therapeutic liquid and/or other contaminants.
- a desiccant system to promote accelerated drying of residual therapeutic liquid and/or other contaminants.
- a non-limiting, non-exhaustive list of such therapeutic agents includes silica gel, calcium oxide, and molecular sieve.
- a tamper evident seal 170, 270 is fitted over a portion of the over cap 160, 260.
- the tamper evident seal 170, 270 is a band that wraps around a portion of the container 110, 210 and/or the over cap 160,
- the tamper evident seal 170, 270 covers all of or substantially all of the container 1 10, 210 and/or the over cap 160, 260.
- the tamper evident seal 170, 270 is configured to break when a force is applied by a user.
- the tamper-evident seal 170, 270 is attached to the over cap 160, 260, and breaking the tamper-evident seal 170, 270 causes the over cap 160, 260 to be removed from the container 110, 210.
- the over cap 160, 260 is configured to be discarded when the tamper-evident seal 170, 270 is removed, leaving the vented cap 140, 240 on the container 1 10, 210.
- breaking of the tamper evident seal does not remove the over cap from container-closure system.
- the tamper-evident seal 370, 470 is configured to be broken and removed without removing the over cap 360, 460.
- the over cap 360, 460 and the vented cap 340, 440 define an integral structure, such that when using the container to apply the therapeutic liquid, the vented cap 340, 440 and the over cap 360, 460 are removed together to provide access to the dispensing tip 330, 430 and replaced after application of a dose of the therapeutic liquid.
- the tearing of the tamper evident seal 370, 470 exposes the vents 345 in the vented cap and/or the over cap.
- the over cap 360, 460 is configured to be removed so as to expose the one or more vents 345 on the vented cap 340, 440, and the vented cap 340, 440 is configured to be removed to expose the dispensing tip 330, 430.
- the over cap includes one or more vents.
- Figures 5-7 illustrate a representative example in which the over cap 560, 660 includes one or more vents and is configured to be rotated with respect to the vented cap 540, 640 and the container 510, 610, such that at least one vent disposed on the over cap and at least one vent disposed on the vented cap 540, 640 overlap causing the dispensing tip 530, 630 to be exposed to the ambient air through the overlapping vents.
- the vented cap 540, 640 and the over cap 560, 660 may define an integral structure or may be separate removable structures as described previously.
- a tamper evident seal 570, 670 is attached to at least one of the over cap 560, 660, and the vented cap 540, 640.
- the tamper evident seal 570, 670 is configured to be broken off from the over cap 560, 660 and/or the vented cap 540, 640.
- Figure 5 shows a container-closure system 500 comprising a vented cap 540 that includes one or more vents 545 and an over cap 560 disposed over at least a portion of the vented cap 540.
- the over cap 560 prevents the one or more vents 545 on the vented cap 540 from allowing ambient air into the cavity between the vented cap 540 and the dispensing tip 530.
- Figure 6 illustrates the same container-closure system 500, 600 as Figure 5, but with the over cap 660 rotated with respect to the vented cap 640. Vents on the over cap 660 at least partially overlap with vents on the vented cap 640, causing the dispensing tip 630 to be exposed to ambient air through the overlapped vents.
- Figure 7 illustrates a cap assembly 701 comprising an over cap and a vented cap. As described previously, in connection with Figures 5 and 6, this representative example includes a vented over cap. Figure 7 shows vents on the over cap partially overlapping with vents on the vented cap, allowing passage of air through the vents. A portion of the vent 746 is covered by a portion 761 of the over cap.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Closures For Containers (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG11201500529TA SG11201500529TA (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
MX2015001220A MX2015001220A (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage. |
KR1020157003519A KR102124667B1 (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
JP2015524463A JP6409192B2 (en) | 2012-07-26 | 2013-07-26 | Double cap system for container closure to maintain aseptic condition of the tip during shelf storage |
CA2879703A CA2879703C (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
AU2013295636A AU2013295636B2 (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
BR112015001755-0A BR112015001755B1 (en) | 2012-07-26 | 2013-07-26 | DOUBLE LID SYSTEM FOR CONTAINER CLOSURES TO MAINTAIN TIP STERILITY DURING SHELF STORAGE |
RU2015105803A RU2644257C2 (en) | 2012-07-26 | 2013-07-26 | Packaging / capping system with two covers to maintain the sterility of the dosing tip during storage |
NZ703922A NZ703922A (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
ES13745320T ES2952616T3 (en) | 2012-07-26 | 2013-07-26 | Dual lid system for container closures to maintain tip sterility during shelf storage |
CN201380039679.9A CN104507440A (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
EP23181718.0A EP4265236A3 (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
EP13745320.5A EP2877138B1 (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
ZA2015/00355A ZA201500355B (en) | 2012-07-26 | 2015-01-16 | Dual cap system for container closures to mantain tip sterility during shelf storage |
HK15111243.5A HK1210408A1 (en) | 2012-07-26 | 2015-11-13 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261675909P | 2012-07-26 | 2012-07-26 | |
US61/675,909 | 2012-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014018847A1 true WO2014018847A1 (en) | 2014-01-30 |
Family
ID=48916275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/052237 WO2014018847A1 (en) | 2012-07-26 | 2013-07-26 | Dual cap system for container-closures to maintain tip sterility during shelf storage |
Country Status (18)
Country | Link |
---|---|
US (3) | US10806628B2 (en) |
EP (2) | EP2877138B1 (en) |
JP (1) | JP6409192B2 (en) |
KR (1) | KR102124667B1 (en) |
CN (2) | CN104507440A (en) |
AU (1) | AU2013295636B2 (en) |
BR (1) | BR112015001755B1 (en) |
CA (1) | CA2879703C (en) |
CO (1) | CO7180200A2 (en) |
ES (1) | ES2952616T3 (en) |
HK (1) | HK1210408A1 (en) |
MX (1) | MX2015001220A (en) |
MY (1) | MY175070A (en) |
NZ (1) | NZ703922A (en) |
RU (1) | RU2644257C2 (en) |
SG (2) | SG11201500529TA (en) |
WO (1) | WO2014018847A1 (en) |
ZA (1) | ZA201500355B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10482167B2 (en) * | 2015-09-24 | 2019-11-19 | Mcafee, Llc | Crowd-source as a backup to asynchronous identification of a type of form and relevant fields in a credential-seeking web page |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610374A (en) * | 1984-10-29 | 1986-09-09 | Dougherty Brothers Company | Apparatus for mixing flowable materials in sealed containers |
US5074440A (en) * | 1990-07-16 | 1991-12-24 | Alcon Laboratories, Inc. | Container for dispensing preservative-free preparations |
US5451374A (en) * | 1993-08-23 | 1995-09-19 | Incutech, Inc. | Medicine vessel stopper |
US5718346A (en) * | 1994-06-02 | 1998-02-17 | Automatic Liquid Packaging, Inc. | Torque-resistant closure with a luer insert for a hermetically sealed container |
US20050139611A1 (en) * | 2002-04-04 | 2005-06-30 | Tomohiko Kubo | Liquid drug container |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB849578A (en) | 1957-11-18 | 1960-09-28 | Mack Robert Fields | Tamper-proof closure for container |
BE789392Q (en) * | 1966-02-25 | 1973-01-15 | Scherico Ltd | FOAM DISPENSER AND MEDICINE PULVERIZER |
US3808611A (en) * | 1971-05-14 | 1974-05-07 | A Neuman | Sewer opening adapter means |
KR880003522Y1 (en) * | 1985-10-30 | 1988-10-12 | 제일제당 주식회사 | Outflow cap of container |
KR900000999B1 (en) | 1986-08-28 | 1990-02-23 | 주식회사 금성사 | Hangul display decoding devices of teletext |
FR2605606B1 (en) | 1986-10-23 | 1989-06-09 | Valois | SECURITY AND INVIOLABILITY DEVICE FOR NASAL-TYPE SPRAYER |
GB2223222B (en) * | 1988-09-30 | 1992-09-16 | Tetra Pak Ltd | Liquid dispensing apparatus for liquid containing cartons |
US5080800A (en) * | 1990-01-08 | 1992-01-14 | Ciba-Geigy Corporation | Process for removing components from solutions |
US5310094A (en) | 1991-11-15 | 1994-05-10 | Jsp Partners, L.P. | Preservative free sterile fluid dispensing system |
SE9201718D0 (en) | 1992-06-03 | 1992-06-03 | Astra Ab | NASAL SPRAY DEVICE |
US6000580A (en) | 1992-06-03 | 1999-12-14 | Astra Aktielbolag | Device for dispensing preservative-free nasal sprays and similar preparations |
US5595314A (en) * | 1994-06-02 | 1997-01-21 | Automatic Liquid Packaging, Inc. | Torque-resistant closure for a hermetically sealed container |
DE9412662U1 (en) | 1994-08-05 | 1994-10-06 | Pfeiffer Erich Gmbh & Co Kg | Discharge device for media |
DE19739989A1 (en) | 1997-09-11 | 1999-03-18 | Pfeiffer Erich Gmbh & Co Kg | Media Donor |
FR2791955B1 (en) | 1999-04-09 | 2001-06-22 | Valois Sa | DEVICE FOR SEALING THE DISPENSING PORT OF A FLUID DISPENSER |
CN2428431Y (en) * | 2000-06-27 | 2001-05-02 | 洪枝火 | Positioned-rotation sealing container |
FR2816600B1 (en) | 2000-11-13 | 2003-03-21 | Michel Faurie | DISPENSING DEVICE FOR DROP FLUID LIQUIDS |
JP4047617B2 (en) * | 2002-04-04 | 2008-02-13 | ニプロ株式会社 | Chemical container |
CN2609546Y (en) * | 2003-02-18 | 2004-04-07 | 凌沛学 | Eye drops bottle |
WO2005014046A2 (en) | 2003-08-07 | 2005-02-17 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes and methods for making and using the same |
US20060011654A1 (en) | 2004-07-16 | 2006-01-19 | Webb Garth T | Disinfectant cap for sterile liquid dispenser |
ITRM20040524A1 (en) | 2004-10-22 | 2005-01-22 | Federigo Federighi | MULTIDOSE DISPENSER BOTTLE FOR PRESERVATIVE-FREE LIQUID PREPARATIONS. |
CA2492255A1 (en) * | 2005-01-11 | 2006-07-11 | Ursapharm Arzneimittel Gmbh & Co. Kg | Fluid dispenser |
CN2781756Y (en) * | 2005-03-18 | 2006-05-24 | 王凤春 | Double-lid original seeds bottle |
US20100108712A1 (en) * | 2005-09-30 | 2010-05-06 | Manesis Nick J | Multi-dose liquid dispensing assembly |
DE102006012898A1 (en) | 2006-03-13 | 2007-09-20 | Ing. Erich Pfeiffer Gmbh | Discharge device for a flowable medium |
ITMO20060252A1 (en) * | 2006-08-04 | 2008-02-05 | Mrp Medical Res & Promotion Es | BOTTLE FOR FLUID CONTAINMENT, PARTICULARLY FOR PHARMACEUTICAL OR SIMILAR PRODUCTS |
CA2680553A1 (en) | 2007-03-13 | 2008-09-18 | 0736413 B.C. Ltd. | Disinfectant cap for sterile liquid dispenser |
DE102007023012A1 (en) | 2007-05-15 | 2008-11-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Atomizer and filter |
ITRM20070275A1 (en) | 2007-05-17 | 2008-11-18 | Federighi Federigo | MULTIDOSE DISPENSER BOTTLE FOR PRESERVATIVE-FREE LIQUID PREPARATIONS. |
EA011751B1 (en) * | 2007-06-18 | 2009-06-30 | Дмитрий Иванович ПАХОМОВ | Closure device |
CA2724339C (en) * | 2008-05-14 | 2017-08-01 | Biolyph, Llc | Reagent preparation and dispensing device and methods for the same |
US8474665B2 (en) * | 2008-07-24 | 2013-07-02 | Sports Pouch Beverage Co., Inc. | Re-sealable spigot for a collapsible beverage container |
DE102009006431B4 (en) | 2009-01-23 | 2010-12-30 | Ing. Erich Pfeiffer Gmbh | discharge |
DE102009006430A1 (en) | 2009-01-23 | 2010-07-29 | Ing. Erich Pfeiffer Gmbh | discharge |
CA2815942A1 (en) | 2010-12-08 | 2012-06-14 | Sanofi-Aventis Deutschland Gmbh | Tamper-evident indicator for a drug reservoir |
US20120279968A1 (en) * | 2011-05-05 | 2012-11-08 | The Andwin Corp. | Child Resistant Dosing Adapter Cap |
US20120312840A1 (en) * | 2011-05-13 | 2012-12-13 | Ayako Hasegawa | Container closure system with integral antimicrobial additives |
US20130020227A1 (en) * | 2011-07-20 | 2013-01-24 | Pharma Vision, LLC | Post-operative cataract kit and method |
DE102011083355B4 (en) | 2011-09-23 | 2013-04-11 | Aptar Radolfzell Gmbh | dropper |
DE102011086755A1 (en) | 2011-11-21 | 2013-05-23 | Aptar Radolfzell Gmbh | Dispenser for dispensing pharmaceutical liquids |
-
2013
- 2013-07-26 RU RU2015105803A patent/RU2644257C2/en active
- 2013-07-26 CN CN201380039679.9A patent/CN104507440A/en active Pending
- 2013-07-26 CN CN202111433061.3A patent/CN114099332A/en active Pending
- 2013-07-26 SG SG11201500529TA patent/SG11201500529TA/en unknown
- 2013-07-26 US US13/952,240 patent/US10806628B2/en active Active
- 2013-07-26 ES ES13745320T patent/ES2952616T3/en active Active
- 2013-07-26 EP EP13745320.5A patent/EP2877138B1/en active Active
- 2013-07-26 MY MYPI2015000186A patent/MY175070A/en unknown
- 2013-07-26 NZ NZ703922A patent/NZ703922A/en unknown
- 2013-07-26 MX MX2015001220A patent/MX2015001220A/en unknown
- 2013-07-26 WO PCT/US2013/052237 patent/WO2014018847A1/en active Application Filing
- 2013-07-26 BR BR112015001755-0A patent/BR112015001755B1/en active IP Right Grant
- 2013-07-26 SG SG10201801222YA patent/SG10201801222YA/en unknown
- 2013-07-26 JP JP2015524463A patent/JP6409192B2/en active Active
- 2013-07-26 CA CA2879703A patent/CA2879703C/en active Active
- 2013-07-26 AU AU2013295636A patent/AU2013295636B2/en active Active
- 2013-07-26 KR KR1020157003519A patent/KR102124667B1/en active IP Right Grant
- 2013-07-26 EP EP23181718.0A patent/EP4265236A3/en active Pending
-
2015
- 2015-01-16 ZA ZA2015/00355A patent/ZA201500355B/en unknown
- 2015-02-02 CO CO15020273A patent/CO7180200A2/en unknown
- 2015-11-13 HK HK15111243.5A patent/HK1210408A1/en unknown
-
2020
- 2020-10-05 US US17/062,863 patent/US20210015661A1/en not_active Abandoned
-
2023
- 2023-06-30 US US18/345,638 patent/US20240074894A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610374A (en) * | 1984-10-29 | 1986-09-09 | Dougherty Brothers Company | Apparatus for mixing flowable materials in sealed containers |
US5074440A (en) * | 1990-07-16 | 1991-12-24 | Alcon Laboratories, Inc. | Container for dispensing preservative-free preparations |
US5451374A (en) * | 1993-08-23 | 1995-09-19 | Incutech, Inc. | Medicine vessel stopper |
US5718346A (en) * | 1994-06-02 | 1998-02-17 | Automatic Liquid Packaging, Inc. | Torque-resistant closure with a luer insert for a hermetically sealed container |
US20050139611A1 (en) * | 2002-04-04 | 2005-06-30 | Tomohiko Kubo | Liquid drug container |
Also Published As
Publication number | Publication date |
---|---|
EP2877138A1 (en) | 2015-06-03 |
JP6409192B2 (en) | 2018-10-24 |
BR112015001755B1 (en) | 2021-08-24 |
US20240074894A1 (en) | 2024-03-07 |
NZ703922A (en) | 2017-04-28 |
KR102124667B1 (en) | 2020-06-18 |
CA2879703C (en) | 2021-11-16 |
SG10201801222YA (en) | 2018-04-27 |
MY175070A (en) | 2020-06-04 |
AU2013295636A1 (en) | 2015-02-05 |
AU2013295636B2 (en) | 2017-12-14 |
RU2015105803A (en) | 2016-09-20 |
BR112015001755A2 (en) | 2017-07-04 |
US20210015661A1 (en) | 2021-01-21 |
CN114099332A (en) | 2022-03-01 |
ES2952616T3 (en) | 2023-11-02 |
ZA201500355B (en) | 2015-12-23 |
HK1210408A1 (en) | 2016-04-22 |
RU2644257C2 (en) | 2018-02-08 |
JP2015529490A (en) | 2015-10-08 |
MX2015001220A (en) | 2015-04-14 |
EP4265236A3 (en) | 2023-11-29 |
SG11201500529TA (en) | 2015-02-27 |
CA2879703A1 (en) | 2014-01-30 |
EP4265236A2 (en) | 2023-10-25 |
CO7180200A2 (en) | 2015-02-09 |
US10806628B2 (en) | 2020-10-20 |
US20140031767A1 (en) | 2014-01-30 |
KR20150034774A (en) | 2015-04-03 |
CN104507440A (en) | 2015-04-08 |
EP2877138B1 (en) | 2023-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6127062B2 (en) | Dispenser for delivering drug liquid | |
JP4159354B2 (en) | Dropping liquid distributor | |
US20120312840A1 (en) | Container closure system with integral antimicrobial additives | |
DK2321191T3 (en) | Bottle for packaging a liquid for dropwise dispensing, with anti-bacterial protection | |
EP2812048B1 (en) | Combined cap applicators | |
US20240074894A1 (en) | Dual cap system for container-closures to maintain tip sterility during shelf storage | |
RU2407682C2 (en) | One-way valve system sealed over entire surface and fluid feed system | |
KR20100029202A (en) | Multidose dispenser for sterile liquid preparations | |
KR102442030B1 (en) | Tube with application tip | |
AU2012256146A1 (en) | Container closure system with integral antimicrobial additives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13745320 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2879703 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2015524463 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2015/001220 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15020273 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013745320 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2013295636 Country of ref document: AU Date of ref document: 20130726 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20157003519 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2015105803 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015001755 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112015001755 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150126 |